Drug Topics

MAY 26, 2025

By protecting pregnant patients from cardiometabolic risk factors, healthier blood pressure can be promoted for children.

504

504

STAT

MAY 26, 2025

For the ailing gene editing industry, hope came earlier this month in the tiny, smiling, fuzzy-headed form of KJ Muldoon. At just 6 months old, KJ received a gene editing treatment custom-built to correct his unique mutation. He’s not cured, researchers explained at the annual American Society of Gene & Cell Therapy meeting in New Orleans.

FDA 137

FDA 137

Drug Topics

MAY 26, 2025

PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.

472

472

Pharmacy Times

MAY 26, 2025

Pharmacists improve outcomes by clarifying and delabeling inaccurate antibiotic allergies.

Labelling 102

Labelling 102

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

MAY 26, 2025

The European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSKs Blenrep.

93

93

pharmaphorum

MAY 26, 2025

Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the disease

91

91

pharmaphorum

MAY 26, 2025

A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight

87

87

Pharmacy Times

MAY 26, 2025

RSV vaccines for pregnant women and infants require careful timing and administration.

Vaccines 65

Vaccines Immunization 65

pharmaphorum

MAY 26, 2025

Changing Faces Agency, consultancy, and investor hires April 2025 Nicole.

52

52

Pharmacy Times

MAY 26, 2025

The authors are optimistic that GADD45A serves as a foundation for therapeutic approaches to slow the progression of heart failure.

65

65

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

MAY 26, 2025

New clinical data suggest potential for the first targeted aldosterone synthase inhibitor to treat uncontrolled or resistant hypertension. Launch-HTN trial is the largest Phase III clinical trial of a novel drug for hypertension. The findings showed that lorundrostat enabled a sustained reduction in blood pressure across a large and diverse population of 1,083 adult patients.

52

52

pharmaphorum

MAY 26, 2025

We saw a range of hires in April in pharma-adjacent sectors like manufacturing and clinical research. Read on for the full update.

52

52

Pharmaceutical Technology

MAY 26, 2025

The EMA has validated the MAA submitted by Soleno Therapeutics for diazoxide choline prolonged-release tablets for Prader-Willi syndrome.

52

52

Pharmaceutical Commerce

MAY 26, 2025

In the final part of his Pharma Commerce video interview, Kevin Dondarski, Deloittes life sciences R&D strategy leader, describes best practices for balancing long-term pipeline sustainability with short-term financial returns.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

MAY 26, 2025

The China NMPA's CDE has granted breakthrough therapy designation approval to Abbisko Therapeutics irpagratinib for HCC.

52

52

Pharma Times

MAY 26, 2025

Company secures regulatory approvals for commercial rollout in UK and US

38

38

Pharmacy Times

MAY 26, 2025

These directives are typically used to shape federal agencies and manage employees in the executive branch.

65

65

Pharma Times

MAY 26, 2025

First non-immunosuppressive dual-action therapy approved for eligible patients

37

37

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 26, 2025

A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring common adverse effects, ensuring timely access to vaccines, and playing a crucial role in supporting patient safety and prevention efforts for RSV.

Vaccines 65

Vaccines 65

STAT

MAY 26, 2025

Harvard University  has long stood on top of the academic world. Thousands from all over seek a coveted spot every year at the Ivy League school with a reputation for cultivating future leaders, from Nobel Prize recipients to high-ranking elected officials. But now, as the standoff between the university and the Trump administration escalates, the appeal of Harvard, and its standing on the global stage, seemingly hangs in the balance.

98

98

Pharmacy Times

MAY 26, 2025

A panelist discusses recent advancements in the respiratory syncytial virus (RSV) vaccine space, including the approval of Arexvy and Abrysvo for older adults and pregnant individuals, the development of promising mRNA and protein subunit vaccines for high-risk groups, and ongoing studies to optimize dosing schedules and booster needs, all aimed at reducing RSV-related hospitalizations and deaths.

Vaccines 65

Vaccines Hospitals 65

The FDA Law Blog

MAY 26, 2025

By Andrew J. Hull & JP Ellison At our webinar earlier this month, we talked about Administration priorities as they relate to the FDC Act and noted that we expect much to remain the same with respect to enforcement. One notable exception has been the Administrations targeting of certain surgical procedures and the use of certain drugs for a particular intended purpose.

Labelling 59

Labelling HIPAA Documentation FDA 59